Stoneridge Investment Partners’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,721
Closed -$38K 165
2025
Q3
$38K Buy
23,721
+2,103
+10% +$2.73K 0.03% 120
2025
Q2
$35K Hold
21,618
0.03% 123
2025
Q1
$26K Hold
21,618
0.02% 114
2024
Q4
$45K Buy
+21,618
New +$50.3K 0.02% 130

Other funds holding GUTS

Stoneridge Investment Partners's GUTS Position: Q4 2025 in Review

Stoneridge Investment Partners sold out of Fractyl Health (GUTS) in Q4 2025, closing a stake of 23,721 shares — an estimated $38K sold.

Stoneridge Investment Partners first reported a position in GUTS in Q4 2024 and held it in 4 quarters. The position peaked at $45K in Q4 2024. 97 funds tracked by Wall St. Rank hold GUTS as of Q4 2025.

  • Stoneridge Investment Partners reported no remaining Fractyl Health position as of Q4 2025 after selling out during the quarter.
  • Stoneridge Investment Partners sold 23,721 Fractyl Health shares in Q4 2025, an estimated $38K.
  • Stoneridge Investment Partners first reported a position in Fractyl Health in Q4 2024 and held it in 4 quarters.
  • Stoneridge Investment Partners's Fractyl Health position peaked at $45K in Q4 2024.
  • 97 funds tracked by Wall St. Rank held Fractyl Health as of Q4 2025.

Based on Stoneridge Investment Partners's 13F filing for Q4 2025, filed 5 Feb 2026.